MNCs Increasingly Investing In Diseases Affecting Developing Countries – IFPMA
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Underscoring what may be a subtle but ongoing change in focus for the industry, pharmaceutical companies appear to be increasingly focused on chronic diseases, child and maternal health and other issues of developing countries